Similar Search Results

Does prescription drug adherence reduce hospitalizations and costs? : the case of diabetes

Encinosa, William E.; Bernard, Didem; Dor, Avi - In: Pharmaceutical markets and insurance worldwide, (pp. 151-173). 2010

Persistent link: https://www.econbiz.de/10008648677

The economics of crowd out under mixed public/private health insurance

Encinosa, William E. - In: Portuguese economic journal 2 (2003) 2, pp. 71-86

Persistent link: https://www.econbiz.de/10002097882

The impact of direct-to-consumer advertising on health insurance markets

Encinosa, William E.; Meyerhoefer, Chad D.; Zuvekas, Samuel - In: The Geneva papers on risk and insurance - issues and … 39 (2014) 4, pp. 749-767

Persistent link: https://www.econbiz.de/10011281017

Optimal health insurance : the case of observable, severe illness

Chernew, Michael; Encinosa, William E.; Hirth, Richard A. - In: Journal of health economics 19 (2000) 5, pp. 585-609

Persistent link: https://www.econbiz.de/10001503672

Competition among health maintenance organizations

Encinosa, William E. - In: Journal of economics & management strategy : JEMS 6 (1997) 1, pp. 129-150

Persistent link: https://www.econbiz.de/10001340281

Pharmaceutical markets and insurance worldwide

Dor, Avi (ed.) - 2010

Persistent link: https://www.econbiz.de/10003929591

Cost sharing, benefit design, and adherence : the case of multiple sclerosis

Dor, Avi; Lage, Maureen J.; Tarrants, Marcy L.; … - In: Pharmaceutical markets and insurance worldwide, (pp. 175-193). 2010

Persistent link: https://www.econbiz.de/10008648670

Welfare consequences of alternative insurance contracts in the mixed for-profit nonprofit hospital market

Dor, Avi - In: Southern economic journal 64 (1997) 3, pp. 698-712

Persistent link: https://www.econbiz.de/10001236244

Pharmaceutical markets and insurance worldwide

Dor, Avi (contributor) - 2010

The fields of pharmaceutical economics and health economics/policy are reaching a point of convergence. This is due to both the widespread availability of pharmaceutical treatments, accompanied by broader insurance coverage, and the regulation of prescription drugs in both private and government...

Persistent link: https://www.econbiz.de/10012049872